alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
UNAUDITED INTERIM FINANCIAL  STATEMENTS INCLUDED IN THE REGISTRANT'S FORM 10-QSB
FOR THE PERIOD ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0000822418
<NAME>                        Bio-Imaging Technologies, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              SEP-30-1998
<PERIOD-START>                                 OCT-01-1998
<PERIOD-END>                                   JUN-30-1999
<EXCHANGE-RATE>                                1
<CASH>                                         424,788
<SECURITIES>                                   0
<RECEIVABLES>                                  1,494,687
<ALLOWANCES>                                   60,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               1,969,453
<PP&E>                                         4,542,174
<DEPRECIATION>                                 3,298,581
<TOTAL-ASSETS>                                 3,421,351
<CURRENT-LIABILITIES>                          1,077,199
<BONDS>                                        65,223
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    104
<COMMON>                                       1,944
<OTHER-SE>                                     2,276,881
<TOTAL-LIABILITY-AND-EQUITY>                   3,421,351
<SALES>                                        0
<TOTAL-REVENUES>                               3,185,245
<CGS>                                          0
<TOTAL-COSTS>                                  1,871,242
<OTHER-EXPENSES>                               1,827,840
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             (11,147)
<INCOME-PRETAX>                                (502,690)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (502,690)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (502,690)
<EPS-BASIC>                                  (0.07) <F1>
<EPS-DILUTED>                                  (0.07) <F2>
<FN>
<F1> -- This amount represents Basic  Earnings per Share in accordance  with the
requirements of Statement of Financial  Accounting Standards No. 128 - "Earnings
per Share."
<F2> -- This amount represents Diluted Earnings per Share in accordance with the
requirements of Statement of Financial  Accounting Standards No. 128 - "Earnings
per Share."
</FN>


</TABLE>
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2505 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2505

 To extend the temporary suspension of duty on 1,4-Benzenedicarboxylic 
acid, polymer with N,N'-bis(2-aminoethyl)-1,2-ethanediamine, cyclized, 
                             methosulfate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 29, 2009

  Mr. Graham introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To extend the temporary suspension of duty on 1,4-Benzenedicarboxylic 
acid, polymer with N,N'-bis(2-aminoethyl)-1,2-ethanediamine, cyclized, 
                             methosulfate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 1,4-BENZENEDICARBOXYLIC ACID, POLYMER WITH N,N'-BIS(2-
              AMINOETHYL)-1,2-ETHANE-DIAMINE, CYCLIZED, METHOSULFATE.

    (a) In General.--Heading 9902.11.93 of the Harmonized Tariff 
Schedule of the United States (relating to 1,4-Benzenedicarboxylic 
acid, polymer with N,N'-bis(2-aminoethyl)-1,2-ethanediamine, cyclized, 
methosulfate) is amended by striking ``12/31/2009'' and inserting ``12/
31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
EXHIBIT 24.4  
 

  SI DIAMOND TECHNOLOGY, INC.  POWER OF ATTORNEY

SI DIAMOND TECHNOLOGY, INC. ANNUAL REPORT ON FORM 10-KSB

             The undersigned, in his capacity as a director of SI Diamond  Technology, Inc. (the "Company"), after reviewing the Company's Form 10-KSB,  does hereby appoint Douglas P. Baker, his true and lawful attorney to execute in his  name, place and stead, in his capacity as a Director of said Company, the  Company's Annual Report on Form 10-KSB for the fiscal year ended December 31,  2001, and all instruments necessary or incidental in connection therewith,  including all amendments, and to file the same with the Securities and Exchange  Commission. Said attorney shall have the full power and authority to do and  perform, in the name and on behalf of the undersigned, in any and all  capacities, every act whatsoever requisite or necessary to be done in the  premises, as fully and to all intents and purposes as the undersigned might or  could do in person, the undersigned hereby ratifying and approving the acts of  said attorney.

             IN TESTIMONY WHEREOF, the undersigned has executed this instrument this  13th day of March, 2002.

                                              /s/ Adam Dunayer                                                  Adam Dunayer
Exhibit 10.2



                         CONSENT OF INDEPENDENT AUDITOR



We consent to the incorporation by reference in the Registration Statement
(Form S-8 No. 33-71822) pertaining to the 1992 Stock Option Plan, of our report
dated February 20, 2002, with respect to the consolidated financial statements
of LanOptics Ltd. included in this Annual Report (Form 20-F/A2) for the year
ended December 31, 2001.




                                                Yours Truly,

                                                /s/ KOST, FORER AND GABBAY
November 27, 2002                                    Kost, Forer and Gabbay
Tel Aviv, Israel                                A Member of Ernst & Young Global
EXHIBIT 23.01





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the incorporation by reference in Registration Statements on Forms S-3 (Registration No.'s 333-1314, 333-15959) and Forms S-8 (Registration No.'s 333-1136, 333-1138) of Sandston Corporation of our report dated March 25, 2011 on the financial statements of Sandston Corporation as of and for the years ended December 31, 2010 and 2009, appearing in the Annual Report on Form 10-K of Sandston Corporation for the year ended December 31, 2010.





/s/ Plante & Moran, PLLCClinton Township, MichiganMarch 25, 2011
Exhibit 23
                       CONSENT OF INDEPENDENT ACCOUNTANTS



We  hereby  consent  to the  incorporation  by  reference  in  the  Registration
Statement on Form S-8  (33-317553) of Watson Wyatt & Company of our report dated
July 23, 1997  appearing  on page F-1 of this Form 10-K.  We also consent to the
incorporation  by reference of our report on the Financial  Statement  Schedule,
which appears on page F-26 of this Form 10-K.



/S/ PRICE WATERHOUSE LLP
------------------------
PRICE WATERHOUSE LLP

Washington, D.C.
September 24, 1997
Second Amendment to the Consulting Agreement



 Exhibit 10.1 
 

 
 SECOND AMENDMENT TO CONFIDENTIAL CONSULTING AGREEMENT 
 This second amendment (the “Second Amendment”) to the Confidential Consulting Agreement dated July 9, 2007 (the “Agreement”) by and between the
parties hereto, is executed as of the date below (the “Effective Date”), by and between Financial Leadership Group, LLC, a California limited liability company (“FLG”), and TiVo, Inc. (“Client”). 
 RECITALS 
 WHEREAS, FLG is in the business of
providing certain financial services; and, 
 WHEREAS, Client wishes to retain FLG to provide and FLG wishes to provide such services to Client on the
terms set forth herein; and, 
 WHEREAS, the parties hereto wish to extend the term of the Agreement; 
 NOW, THEREFORE, in consideration of the mutual covenants set forth in the Agreement, the parties hereto agree as follows: 
  

			
	 1.    Term.
	  	The term of the Agreement is hereby extended until November 9, 2007, and shall automatically renew in 30 day increments.
		
	 2.    Termination.
	  	Paragraph 4(B) of the Agreement is amended to provide for 30 days’ notice of termination.
		
	 3.    Miscellaneous.
	  	All other terms and conditions of the Agreement remain unchanged. This Second Amendment shall be incorporated in the Agreement as Exhibit C.

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the Effective Date. 

 

									
	 CLIENT:
  
 TiVo Inc.,
  
 a Delaware corporation.
	 		 	 FLG:
  
 Financial Leadership Group, LLC,
  
 a California limited
liability company.

					
	By:	 	Nancy Kato	 		 	By:	 	Jeffrey S. Kuhn
					
	Signed:	 	/s/ Nancy Kato	 		 	Signed:	 	/s/ Jeffrey S. Kuhn
					
	Title:	 	Senior Vice President, Human Resources	 		 	Title:	 	Managing Partner
				
	Address:	 	 2160 Gold Street
 P.O. Box 2160
 Alviso, CA 95002
	 		 	Effective Date: October 2, 2007.
					
	Tel:	 	(408) 519-9100	 		 		 	
					
	Fax:	 	(408) 519-5330	 		 		 	
					
	Email:	 	nancykato@tivo.com	 		 		 	

 REMAINDER OF THIS PAGE LEFT BLANK
#### In the Matter of Sean Wilson, Appellant, v Caroline Kilkenny, Respondent.

Submitted July 12, 2010;

decided September 2, 2010

Motion for leave to appeal dismissed upon the ground that the order sought to be appealed from does not finally determine the proceeding within the meaning of the Constitution.
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 96-41227

Summary Calendar

 

BARBARA GUNERATNE,

Plaintiff-Appellant,

versus

ST. MARY’S HOSPITAL,

Defendant-Appellee.

- - - - - - - - - -

Appeal from the United States District Court

for the Southern District of Texas

USDC No. G-95-CV-676

- - - - - - - - - -

June 18, 1997

Before Wisdom, King, and Smith, Circuit Judges.

PER CURIAM:*

Barbara Guneratne filed this action against St. Mary’s

Hospital alleging that the hospital unlawfully discriminated

against her in violation of Title VII of the Civil Act of 1964,

42 U.S.C. §§ 12101-12117, and 12201-12213 (also known as the

Americans with Disability Act), and in violation of the

Rehabilitation Act of 1973. Guneratne also asserted a claim for
No. 96-41227

- 2 -

retaliation in violation of the Texas Worker’s Compensation Act. 

The district court granted summary judgment in St. Mary’s favor

and dismissed all claims. Guneratne appeals. 

Guneratne contends that district court erred in finding that

she was unable to perform the essential functions of a clinical

nurse and that the hospital could not make a reasonable

accommodation for her. We have reviewed the record de novo and

agree with the district court’s analysis. Accordingly, we AFFIRM

for the reasons stated by the district court. See Guneratne v.

St. Mary’s Hospital, No. G-95-676 (S.D. Tex. Nov. 1, 1996).
[Federal Register Volume 74, Number 105 (Wednesday, June 3, 2009)]
[Notices]
[Page 26711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12878]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Environmental Health Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Environmental Health 
Sciences Special Emphasis Panel; Environmental Sensors for Personal 
Exposure Assessment Administrative Meeting.
    Date: June 17, 2009.
    Time: 1 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIEHS Keystone, Keystone Park, 530 Davis Drive, Durham, 
NC 27713 (Telephone Conference Call).
    Contact Person: RoseAnne M McGee, Associate Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research 
and Training, Nat. Institute of Environmental Health Sciences, P.O. 
Box 12233, MD EC-30, Research Triangle Park, NC 27709, (919) 541-
0752, <a href="/cdn-cgi/l/email-protection#dc91bfbbb9b9ed9cb2b5b9b4aff2b2b5b4f2bbb3aa"><span class="__cf_email__" data-cfemail="175a747072722657797e727f6439797e7f39707861">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.115, 
Biometry and Risk Estimation--Health Risks from Environmental 
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety 
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic 
Research and Education; 93.894, Resources and Manpower Development 
in the Environmental Health Sciences; 93.113, Biological Response to 
Environmental Health Hazards; 93.114, Applied Toxicological Research 
and Testing, National Institutes of Health, HHS)

    Dated: May 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12878 Filed 6-2-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Ex-10.1



 






Exhibit 10.1




FOURTH AMENDMENT TO PINNACLE FINANCIAL PARTNERS, INC.

2004 EQUITY INCENTIVE PLAN




     WHEREAS, the Board of Directors and shareholders of Pinnacle Financial Partners, Inc., a
Tennessee corporation (the “Company”), have previously adopted the 2004 Equity Incentive Plan (the
“Plan”);



     Whereas, the Board of Directors and shareholders have previously adopted Amendments No. 1, No.
2 and No. 3 to the Plan;



     WHEREAS, pursuant to Section 13.1 of the Plan, the Company’s Board of Directors has retained
the right to amend the Plan; and



     WHEREAS, the Company’s Board of Directors now desires to amend the Plan;



     NOW, THEREFORE, IN CONSIDERATION of the premises and by resolution of the Company’s Board of
Directors, the Plan is hereby amended as follows:



     1. The first sentence of Section 4.1 is deleted in its entirety and replaced with the
following:




“Subject to the provisions of Section 4.2 hereof, the stock to be subject to Awards under the
Plan shall be the Shares of the Company and the maximum number of Shares with respect to which
Awards may be granted under the Plan shall be 1,779,510 which includes 29,510 shares with
respect to awards which were authorized but not granted under the Pinnacle Financial Partners,
Inc. 2000 Stock Incentive Plan (the “2000 Plan”)”.



     2. Except as expressly stated herein, all other portions of the Plan remain in full force and
effect.



     3. This Fourth Amendment to the Pinnacle Financial Partners, Inc. 2004 Equity Incentive Plan
is effective this 27th day of November, 2007; provided it has been approved by the
Company’s Board of Directors and the Company’s shareholders.



	 	 	 	 	 
	 	PINNACLE FINANCIAL PARTNERS, INC.

 	 
	 	By:  	/s/ M. Terry Turner
 	 
	 	 	Name:  	M. Terry Turner 	 
	 	 	Title:  	President and Chief Executive Officer
EXHIBIT 99.2





Certification Pursuant to 18
U.S.C. Section 1350,

As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the quarterly report of Catalina Lighting,
Inc. (the Company) on Form 10-Q for the period ended December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Stephen G. Marble, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(a) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(b) The information contained in the Report
presents fairly, in all material respects, the financial condition and results of operations of the Company.



Chief Financial Officer



|                     
|---------------------
|/s/ Stephen G. Marble
|Stephen G. Marble    



Date: February 14, 2003
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2658 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2658

  To extend temporarily the suspension of duty on strontium magnesium 
                phosphate-tin doped inorganic products.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 2, 2009

  Mr. Bunning introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To extend temporarily the suspension of duty on strontium magnesium 
                phosphate-tin doped inorganic products.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. STRONTIUM MAGNESIUM PHOSPHATE-TIN DOPED INORGANIC PRODUCTS.

    (a) In General.--Heading 9902.22.68 of the Harmonized Tariff 
Schedule of the United States (relating to strontium magnesium 
phosphate-tin doped inorganic products) is amended by striking the date 
in the effective period column and inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains financial information extracted from the financial
statements of HEARx LTD and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-26-1997
<PERIOD-START>                             DEC-28-1996
<PERIOD-END>                               SEP-26-1997
<CASH>                                       2,602,280
<SECURITIES>                                14,286,513
<RECEIVABLES>                                3,504,844
<ALLOWANCES>                                 (688,047)
<INVENTORY>                                    419,744
<CURRENT-ASSETS>                            20,285,500
<PP&E>                                      12,833,380
<DEPRECIATION>                             (4,144,607)
<TOTAL-ASSETS>                              30,138,949
<CURRENT-LIABILITIES>                        3,701,074
<BONDS>                                        182,999
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      7,215
<COMMON>                                     9,918,716
<OTHER-SE>                                  16,328,945
<TOTAL-LIABILITY-AND-EQUITY>                30,138,949
<SALES>                                     17,347,775
<TOTAL-REVENUES>                            17,345,775
<CGS>                                        4,835,015
<TOTAL-COSTS>                               25,553,178
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (6,205,403)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,205,403)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                              1,885,026
<CHANGES>                                            0
<NET-INCOME>                               (8,090,429)
<EPS-PRIMARY>                                    (.09)
<EPS-DILUTED>                                    (.09)
        

</TABLE>
#### In the Matter of Dashawn N. Westchester County Department of Social Services, Respondent; Youvonne N., Appellant. (Proceeding No. 1.) In the Matter of Judae N. Westchester County Department of Social Services, Respondent; Youvonne N., Appellant. (Proceeding No. 2.) In the Matter of Nicholas N. Westchester County Department of Social Services, Respondent; Youvonne N., Appellant. (Proceeding No. 3.) In the Matter of Kelsey N.-C. Westchester County Department of Social Services, Respondent; Youvonne N., Appellant. (Proceeding No. 4.)

[974 NYS2d 509]

In related child neglect proceedings pursuant to Family Court Act article 10, the mother appeals, as limited by her brief, from so much of an order of the Family Court, Westchester County (Recine, Ct. Atty. Ref.), dated November 15, 2012, as, after a permanency hearing held on October 19, 2012, approved the permanency goal of adoption as to Kelsey N.-C.

Ordered that the order is reversed insofar as appealed from, on the law, without costs or disbursements, and the matter is remitted to the Family Court, Westchester County, for further proceedings, if still necessary, pursuant to this Court’s determination in *Matter of Dashawn N. (Youvonne N.)*(101 AD3d 1013 [2012]).

In a December 19, 2012, decision and order on the mother’s appeals from certain determinations made by a court attorney referee following a May 4, 2012, permanency hearing, this Court reversed the orders appealed from, granted the mother’s motion to vacate the determinations on the ground that she was denied her rights to counsel and due process, and remitted the matter to the Family Court, Westchester County, for a new hearing before a different court attorney referee and a new determination regarding the permanency goal for Kelsey N.-C. *(see Matter of Dashawn N. [Youvonne N.],*101 AD3d 1013 [2012]). Before this Court’s decision and order was released, however, the same court attorney referee issued an order dated November 15, 2012, approving the permanency goal of adoption for Kelsey N.-C, and the mother now appeals from that order.

As the mother correctly contends, since the November 15, 2012, order was decided by the same court attorney referee who issued the orders that were reversed on the prior appeal, and who was removed from the case by this Court’s December 19, 2012, decision and order based on her denial of the mother’s rights to counsel and due process, the order must be reversed insofar as appealed from and the matter must be remitted to *641the Family Court, Westchester County, for further proceedings, if still necessary, pursuant to this Court’s determination in *Matter of Dashawn N. (Youvonne N.)*(101 AD3d 1013 [2012]).

The mother’s remaining contention, regarding the alleged ineffective assistance of counsel she received during the proceeding to terminate her parental rights as to the child Nicholas N., is not properly before this Court on this appeal from the order dated November 15, 2012. Mastro, J.E, Dillon, Angiolillo and Chambers, JJ., concur.